top of page
it's where dermatology lives



Psoriasis: Long term studies of biologics demonstrate benefits are maintained over time
The availability of treatments like brodalumab and guselkumab in the u.S. in 2017, and the anticipated commercial availability of these...
by Louise Gagnon
Apr 3, 20184 min read


MDD may be associated with increased risk of PsA in patients with psoriasis
Risk of PsA higher in patients with MDD
by Lynn Bradshaw
Mar 22, 20183 min read


Vitamin D supplements may improve psoriasis symptoms
Some patients with psoriasis may see an improvement in their symptoms by taking oral vitamin D supplements, especially during the colder mon
by Bianca Quijano
Mar 20, 20182 min read


Ustekinumab also reduces aortic vascular inflammation
“This study represents promise that this treatment may reduce the risk of heart attack and stroke in the future. It’s an encouraging finding
by Bianca Quijano
Mar 5, 20182 min read


Standardized technique improves trichloroacetic acid peel outcomes
Fitzpatrick skin type a poor predictor of TCA peel results; origin of ancestors provides improved prognosis
by John Evans
Jan 11, 20184 min read


World Psoriasis Day 2017 to focus on psychological impacts of condition
World Psoriasis Day is on Oct. 29, 2017. The International Federation of Psoriasis Associations (IFPA) and its members in more than 50 count
by Emily Innes-Leroux
Oct 27, 20172 min read


New vaccine may mean less expensive treatment for psoriasis, allergies
“By creating a vaccine that stimulates the body to make antibodies against Interleukin 17 itself we can replace the need for frequent and ex
John Evans, Associate Editor
Oct 23, 20172 min read


Blocking IL-36 appears safe, effective for treating plaque psoriasis
“After a series of tests carried out by Dr. Satveer Mahil at St. John’s Institute of Dermatology [at King’s College, London], we determined
by John Evans, Associate Editor
Oct 17, 20172 min read
Featured Posts




bottom of page